Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats

Calcified Tissue International

Volumn 77, Issue 2, 2005, Pages 119-126

  Iwamoto, J ^a   Yeh, J K ^b   Schmidt, A ^c   Rowley, E ^c   Stanfield, L ^c   Takeda, T ^a   Sato, M ^c  

^a KEIO UNIVERSITY   (Japan)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Female; Osteoporosis; Raloxifene; Rat; Vitamin K

Indexed keywords

CHOLESTEROL; DEOXYPYRIDINOLINE; DRUG VEHICLE; ESTROGEN; FARNOQUINONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE EROSION; BONE STRENGTH; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN BLOOD LEVEL; FEMALE; FEMUR NECK; FEMUR SHAFT; METAPHYSIS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PERIOSTEUM; PRIORITY JOURNAL; PROPHYLAXIS; TIBIA; URINE LEVEL; VERTEBRA; ANIMAL; BLOOD; BONE DEVELOPMENT; COMPRESSIVE STRENGTH; DISEASE MODEL; DRUG COMBINATION; LUMBAR VERTEBRA; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BONE DENSITY; COMPRESSIVE STRENGTH; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; FEMUR NECK; LUMBAR VERTEBRAE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY; SELECTIVE ESTROGEN RECEPTOR MODULATORS; VITAMIN K 2;

EID: 27144468066     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0277-8     Document Type: Article

References (26)

1. A Cranney G Guyatt L Griffith G Wells P Tugwell C Rosen 2002 Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis Endocr Rev 23 570 578
2. A Cranney P Tugwell G Wells G Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology Endocr Rev 23 496 507
3. M Sato TA Grese JA Dodge HU Bryant CH Turner 1999 Emerging therapies for the prevention or treatment of postmenopausal osteoporosis J Med Chem 42 1 24
4. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis J Bone Miner Res 15 515 521
5. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Gluer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282 637 645
6. PV Hauschka JB Lian DE Cole CM Gundberg 1989 Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone Physiol Rev 69 990 1047
7. 2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study Jpn J Pharmacol 80 67 74
8. 2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats Bone 31 575 581
9. 2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats J Bone Miner Res 18 776 783
10. DB Kimmel 1996 Animal Models for in vivo experimentation in osteoporosis research R Marcus D Feldman J Kelsey Osteoporosis Academic Press San Diego 671 690
11. 2 on three-dimensional trabecular microarchitecture in ovariectbmized rats J Bone Miner Res 15 1810 1817
12. M Sato J Kim LL Short CW Slemenda HU Bryant 1995 Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats J Pharmacol Exp Ther 272 1252 1259
13. M Sato C McClintock J Kim CH Turner HU Bryant D Magee CW Slemenda 1994 Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats J Bone Miner Res 9 715 724
14. M Sato MK Rippy HU Bryant 1996 Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats FASEB J 10 905 912
15. RG Erben 1997 Embedding of bone samples in methymethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry J Histochem Cytochem 45 307 313
16. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2 595 610
17. CH Turner DB Burr 1993 Basic biomechanical measurements of bone: a tutorial Bone 14 595 608
18. RT Turner GL Evans GK Wakley 1994 Reduced chondroclust differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134 461 466
19. N Binkley D Krueger J Engelke T Crenshaw J Suttie 2002 Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats Bone 30 897 900
20. CH Turner M Sato HU Bryant 1994 Raloxifene preserves bone strength and bone mass in ovariectomized rats Endocrinology 135 2001 2005
21. M Sato HU Bryant P Iversen J Helterbrand F Smietana K Bemis R Higgs CH Turner I Owan Y Takano DB Burr 1996 Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats J Pharmacol Exp Ther 279 298 305
22. A Cranney P Tugwell J Adachi B Weaver N Zytaruk A Papaioannou V Robinson B Shea G Wells G Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23 517 523
23. A Cranney P Tugwell N Zytaruk V Robinson B Weaver J Adachi G Wells B Shea G Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 23 524 528
24. A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23 508 516
25. Y Nagasawa M Fujii Y Kajimoto E Imai M Hori 1998 Vitamin K and serum cholesterol in patients on continuous ambulatory peritoneal dialysis Lancet 351 724
26. T Ohyashiki Y Yabunaka K Matsui 1991 Antioxidant effect of vitamin K homologues on ascorbic acid/Fe(2+)-induced lipid peroxidation of lecithin liposomes Chem Pharm Bull 39 976 979